Assay Detail
Functional
CHEMBL873875
Review assay metadata, readout intent, target linkage, and publication context from the same page.
The compound was tested for the concentration to inhibit 50% of MDA-231 breast cancer cell lines.
13
Total Activities
13
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | MDA-MB-231 |
| Confidence | 1 — Organism |
| Curated By | Intermediate |
Publication
Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 13 | 7.10 | 8.30 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL135778 | — | — | 1 | 8.30 |
| CHEMBL337526 | — | — | 1 | 8.00 |
| CHEMBL137098 | — | — | 1 | 7.68 |
| CHEMBL423534 | — | — | 1 | 7.64 |
| CHEMBL334497 | — | — | 1 | 7.57 |
| CHEMBL335700 | — | — | 1 | 7.08 |
| CHEMBL335643 | — | — | 1 | 6.82 |
| CHEMBL101299 | — | — | 1 | 6.80 |
| CHEMBL335387 | — | — | 1 | 6.72 |
| CHEMBL422988 | — | — | 1 | 6.46 |
| CHEMBL137263 | — | — | 1 | 6.42 |
| CHEMBL339379 | — | — | 1 | 5.66 |
| CHEMBL337205 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL135778 | — | IC50 | = | 5.0 | nM | 8.30 |
| CHEMBL337526 | — | IC50 | = | 10.0 | nM | 8.00 |
| CHEMBL137098 | — | IC50 | = | 21.0 | nM | 7.68 |
| CHEMBL423534 | — | IC50 | = | 23.0 | nM | 7.64 |
| CHEMBL334497 | — | IC50 | = | 27.0 | nM | 7.57 |
| CHEMBL335700 | — | IC50 | = | 84.0 | nM | 7.08 |
| CHEMBL335643 | — | IC50 | = | 150.0 | nM | 6.82 |
| CHEMBL101299 | — | IC50 | = | 160.0 | nM | 6.80 |
| CHEMBL335387 | — | IC50 | = | 190.0 | nM | 6.72 |
| CHEMBL422988 | — | IC50 | = | 350.0 | nM | 6.46 |
| CHEMBL137263 | — | IC50 | = | 380.0 | nM | 6.42 |
| CHEMBL339379 | — | IC50 | = | 2200.0 | nM | 5.66 |
| CHEMBL337205 | — | IC50 | > | 1000000.0 | nM | - |